ArticleOncotarget2016

The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias.

Joanna Zabkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.